<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>KO-Listed — Portfolio on 6ix</title>
<link>https://6ix.com/p/ko-listed</link>
<description>Top companies trading on KO, ranked by market cap.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 02:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/portfolio/ko-listed" rel="self" type="application/rss+xml" />
<item>
<title>NETMARBLE TO HOST CHARACTER NAME RESERVATION EVENT FOR GAME OF THRONES: KINGSROAD ON MAY 8</title>
<link>https://6ix.com/news/netmarble-to-host-character-name-reservation-event-for-game-of-thrones-kingsroad-on-may-8</link>
<guid isPermaLink="true">https://6ix.com/news/netmarble-to-host-character-name-reservation-event-for-game-of-thrones-kingsroad-on-may-8</guid>
<pubDate>Thu, 30 Apr 2026 02:30:00 GMT</pubDate>
<description>Netmarble, a leading developer and publisher of high-quality games, announced that it will host a character name reservation event for Game of Thrones: Kingsroad starting May 8 at 05:00 AM(UTC).</description>
</item>
<item>
<title>LG Energy Solution Releases 2026 First-Quarter Financial Results</title>
<link>https://6ix.com/news/lg-energy-solution-releases-2026-first-quarter-financial-results</link>
<guid isPermaLink="true">https://6ix.com/news/lg-energy-solution-releases-2026-first-quarter-financial-results</guid>
<pubDate>Thu, 30 Apr 2026 01:16:00 GMT</pubDate>
<description>LG Energy Solution (KRX: 373220) today announced its first-quarter earnings for 2026, reporting an increased quarterly revenue mainly driven by stable demand and solid orders for both 46-Series cylindrical EV batteries and ESS batteries.</description>
</item>
<item>
<title>KUMHO TIRE U.S.A. APPOINTS CAROLINA WAGNER VICE PRESIDENT OF MARKETING</title>
<link>https://6ix.com/news/kumho-tire-usa-appoints-carolina-wagner-vice-president-of-marketing</link>
<guid isPermaLink="true">https://6ix.com/news/kumho-tire-usa-appoints-carolina-wagner-vice-president-of-marketing</guid>
<pubDate>Mon, 27 Apr 2026 11:13:00 GMT</pubDate>
<description>Kumho Tire U.S.A., one of the world's leading tire manufacturers, announces the appointment of Carolina Wagner as Vice President of Marketing. This strategic hire underscores Kumho Tire's commitment to strengthening its brand positioning and elevating its competitive presence in the U.S. passenger, light truck, and commercial vehicle segments.</description>
</item>
<item>
<title>LG ELECTRONICS PRESENTS HYBRID EMERGENCY CALL SOLUTION AT 5GAA IN SWEDEN</title>
<link>https://6ix.com/news/lg-electronics-presents-hybrid-emergency-call-solution-at-5gaa-in-sweden</link>
<guid isPermaLink="true">https://6ix.com/news/lg-electronics-presents-hybrid-emergency-call-solution-at-5gaa-in-sweden</guid>
<pubDate>Mon, 27 Apr 2026 01:00:00 GMT</pubDate>
<description>LG Electronics (LG) showcased its Hybrid Emergency Call (Hybrid eCall) solution at the 37th Meeting Week of the 5G Automotive Association (5GAA) – a global cross-industry organization driving the development of connected mobility solutions – held in Gothenburg, Sweden, on April 23. The solution highlights LG's telematics control unit (TCU) capabilities and its continued focus on vehicle connectivity technologies aligned with evolving European safety regulations.</description>
</item>
<item>
<title>HD Hyundai Heavy Industries Wins South Korea's First Overseas Icebreaker Order</title>
<link>https://6ix.com/news/hd-hyundai-heavy-industries-wins-south-koreas-first-overseas-icebreaker-order</link>
<guid isPermaLink="true">https://6ix.com/news/hd-hyundai-heavy-industries-wins-south-koreas-first-overseas-icebreaker-order</guid>
<pubDate>Mon, 27 Apr 2026 00:00:00 GMT</pubDate>
<description>HD Hyundai Heavy Industries has become the first Korean shipbuilder to secure an overseas order for a dedicated icebreaker.</description>
</item>
<item>
<title>iMarketKorea Signs Two MOUs with Vietnam's Phu Tho Provincial People's Committee and BIDV</title>
<link>https://6ix.com/news/imarketkorea-signs-two-mous-with-vietnams-phu-tho-provincial-peoples-committee-and-bidv</link>
<guid isPermaLink="true">https://6ix.com/news/imarketkorea-signs-two-mous-with-vietnams-phu-tho-provincial-peoples-committee-and-bidv</guid>
<pubDate>Sun, 26 Apr 2026 23:42:00 GMT</pubDate>
<description>iMarketKorea, a leading industrial materials distribution company led by CEO Kim Hak-jae, announced that it has signed two Memoranda of Understanding (MOUs) with the Phu Tho Provincial People's Committee and Bank for Investment and Development of Vietnam during the MOU signing session at the Korea-Vietnam Business Forum, hosted by Korea's Ministry of Trade, Industry and Energy and the Korea Chamber of Commerce and Industry. The company participated in the official Korea-Vietnam economic delegati</description>
</item>
<item>
<title>Daewoong Pharmaceutical Co., Ltd.: Daewoong Pharmaceutical Hosts 'NABOTA Master Class'… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments</title>
<link>https://6ix.com/company/daewoong-pharma/news/daewoong-pharmaceutical-hosts-nabota-master-class-highlighting-safety-amid-growing-demand-for-high-dose-repetitive-treatments</link>
<guid isPermaLink="true">https://6ix.com/company/daewoong-pharma/news/daewoong-pharmaceutical-hosts-nabota-master-class-highlighting-safety-amid-growing-demand-for-high-dose-repetitive-treatments</guid>
<pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
<description>Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Changjae Lee) announced that it successfully hosted its global medical education program, the NABOTA Master Class (NMC) Spring in Korea.</description>
</item>
<item>
<title>Strawberry Fields REIT Announces First Quarter 2026 Earnings Release, Conference Call and Webcast</title>
<link>https://6ix.com/news/strawberry-fields-reit-announces-first-quarter-2026-earnings-release-conference-call-and-webcast</link>
<guid isPermaLink="true">https://6ix.com/news/strawberry-fields-reit-announces-first-quarter-2026-earnings-release-conference-call-and-webcast</guid>
<pubDate>Fri, 24 Apr 2026 10:30:00 GMT</pubDate>
<description>SOUTH BEND, Ind., April 24, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) announced today that it will report its first quarter 2026 financial results before the market opens on May 8, 2026. Further, on May 8, 2026 at 12:00 p.m. Eastern Time, the Company’s management team will be holding a conference call/webcast to discuss the 2026 first quarter results and invites current and prospective investors to join. To access the conference call, please pre-</description>
</item>
<item>
<title>SK Group Establishes Foundation for AI Collaboration with Vietnam</title>
<link>https://6ix.com/news/sk-group-establishes-foundation-for-ai-collaboration-with-vietnam</link>
<guid isPermaLink="true">https://6ix.com/news/sk-group-establishes-foundation-for-ai-collaboration-with-vietnam</guid>
<pubDate>Fri, 24 Apr 2026 01:47:00 GMT</pubDate>
<description>SK Group announced it will collaborate with Vietnam to build the country's artificial intelligence (AI) industry ecosystem and develop core AI infrastructure.</description>
</item>
<item>
<title>Orion Group Interim report January–March 2026</title>
<link>https://6ix.com/news/orion-group-interim-report-january-march-2026</link>
<guid isPermaLink="true">https://6ix.com/news/orion-group-interim-report-january-march-2026</guid>
<pubDate>Thu, 23 Apr 2026 09:00:00 GMT</pubDate>
<description>ORION CORPORATION INTERIM REPORT 1–3/2026 23 APRIL 2026 at 12:00 EEST Orion Group Interim report January–March 2026 January–March 2026 Highlights Net sales totalled EUR 417.7 (January–March 2025: 354.6) million Operating profit was EUR 114.8 (77.9) millionBasic earnings per share were EUR 0.64 (0.44)Cash flow from operating activities per share was EUR 0.26 (0.55)The outlook for 2026 is specified: Net sales are estimated to be EUR 1,950 million to EUR 2,100 million. Operating profit is estimated</description>
</item>
<item>
<title>Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours</title>
<link>https://6ix.com/news/orion-pharma-initiates-teadco-phase-1b2-basket-trial-evaluating-odm-212-in-combination-with-standard-of-care-treatments-in-patients-with-select-advanced-solid-tumours-2</link>
<guid isPermaLink="true">https://6ix.com/news/orion-pharma-initiates-teadco-phase-1b2-basket-trial-evaluating-odm-212-in-combination-with-standard-of-care-treatments-in-patients-with-select-advanced-solid-tumours-2</guid>
<pubDate>Thu, 23 Apr 2026 06:00:00 GMT</pubDate>
<description>ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours Orion Corporation (Orion Pharma) today announced the initiation of a Phase 1b/2 basket trial evaluating ODM-212, a potential best-in-class, oral pan-TEAD inhibitor, in combination with standard of care treatments in advanced mesothelioma, KRAS G12C mutated non-small cell</description>
</item>
<item>
<title>Adbiotech Co., Ltd.: Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)</title>
<link>https://6ix.com/company/adbiotech-co-ltd/news/exicure-announces-co-development-agreement-with-adbiotech-for-burixafor-gpc-100-1</link>
<guid isPermaLink="true">https://6ix.com/company/adbiotech-co-ltd/news/exicure-announces-co-development-agreement-with-adbiotech-for-burixafor-gpc-100-1</guid>
<pubDate>Wed, 22 Apr 2026 23:54:00 GMT</pubDate>
<description>CHICAGO, April 22, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based biotechnology company, to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. The collaboration will focus on evaluating combination strategies involving Burixafor (GPC-100) in indications including sickle cell disease (SCD), acute myeloid leukemia (AML), and</description>
</item>
<item>
<title>SOLUM Launches Newton Core+, a Next-Generation ESL, in the UK at Retail Technology Show 2026</title>
<link>https://6ix.com/news/solum-launches-newton-core-a-next-generation-esl-in-the-uk-at-retail-technology-show-2026</link>
<guid isPermaLink="true">https://6ix.com/news/solum-launches-newton-core-a-next-generation-esl-in-the-uk-at-retail-technology-show-2026</guid>
<pubDate>Wed, 22 Apr 2026 08:00:00 GMT</pubDate>
<description>LONDON, April 22, 2026--SOLUM introduces Newton Core+ as a next-generation ESL platform at Retail Technology Show 2026 in London, showcasing its "Retail in Sync" ecosystem.</description>
</item>
<item>
<title>Samsung Biologics Reports First Quarter 2026 Financial Results</title>
<link>https://6ix.com/news/samsung-biologics-reports-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/news/samsung-biologics-reports-first-quarter-2026-financial-results</guid>
<pubDate>Wed, 22 Apr 2026 06:50:00 GMT</pubDate>
<description>Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), reported financial results for the first quarter of fiscal year 2026.</description>
</item>
<item>
<title>Celltrion, Inc.: Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)</title>
<link>https://6ix.com/company/celltrion-inc/news/celltrion-to-present-seven-abstracts-in-inflammatory-bowel-disease-ibd-at-2026-digestive-disease-weekr-ddw</link>
<guid isPermaLink="true">https://6ix.com/company/celltrion-inc/news/celltrion-to-present-seven-abstracts-in-inflammatory-bowel-disease-ibd-at-2026-digestive-disease-weekr-ddw</guid>
<pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
<description>Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster presentations will feature data including post-hoc analysis of its pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA®, the first and only FDA-approved subcutaneous infliximab.</description>
</item>
<item>
<title>LG ELECTRONICS SHOWCASES AN EXPANDED BUILT-IN PORTFOLIO WITH SKS AND LG BUILT-IN LINEUPS AT EUROCUCINA 2026</title>
<link>https://6ix.com/news/lg-electronics-showcases-an-expanded-built-in-portfolio-with-sks-and-lg-built-in-lineups-at-eurocucina-2026</link>
<guid isPermaLink="true">https://6ix.com/news/lg-electronics-showcases-an-expanded-built-in-portfolio-with-sks-and-lg-built-in-lineups-at-eurocucina-2026</guid>
<pubDate>Tue, 21 Apr 2026 05:26:00 GMT</pubDate>
<description>LG Electronics (LG) is showcasing its built-in kitchen solutions, including its SKS luxury brand lineup and new LG Built-in package, at EuroCucina 2026 – the international kitchen exhibition held as part of Milan Design Week – in Milan, Italy, from April 21–26. The exhibition presents a wide range of solutions tailored to European lifestyles and preferences and reflects LG's strategy to strengthen its presence in the European built-in market.</description>
</item>
<item>
<title>Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA</title>
<link>https://6ix.com/news/orion-pharmas-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda</link>
<guid isPermaLink="true">https://6ix.com/news/orion-pharmas-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda</guid>
<pubDate>Mon, 20 Apr 2026 13:00:00 GMT</pubDate>
<description>ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for the treatment of mesothelioma, which is a rare and difficult to treat cancer. The FDA grants orphan drug designation to investigational therapies addressing rare diseases or</description>
</item>
<item>
<title>LG Innotek to Supply Cutting-Edge Automotive Wi-Fi 7 Communication Module to a leading European automotive parts company</title>
<link>https://6ix.com/news/lg-innotek-to-supply-cutting-edge-automotive-wi-fi-7-communication-module-to-a-leading-european-automotive-parts-company-1</link>
<guid isPermaLink="true">https://6ix.com/news/lg-innotek-to-supply-cutting-edge-automotive-wi-fi-7-communication-module-to-a-leading-european-automotive-parts-company-1</guid>
<pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
<description>LG Innotek (CEO Moon Hyuksoo) announced on the 20th of this month that it will supply its Automotive Wi-Fi 7 Communication Module, featuring cutting-edge Wi-Fi technology, to a leading European automotive parts company.</description>
</item>
<item>
<title>Penetrium Bioscience Unveils Breakthrough Mechanism Solving 137-Year-Old "Seed & Soil" Paradigm, Opening a New Era for Targeted Cancer Therapy</title>
<link>https://6ix.com/news/penetrium-bioscience-unveils-breakthrough-mechanism-solving-137-year-old-seed-and-soil-paradigm-opening-a-new-era-for-targeted-cancer-therapy</link>
<guid isPermaLink="true">https://6ix.com/news/penetrium-bioscience-unveils-breakthrough-mechanism-solving-137-year-old-seed-and-soil-paradigm-opening-a-new-era-for-targeted-cancer-therapy</guid>
<pubDate>Fri, 17 Apr 2026 07:48:00 GMT</pubDate>
<description>Penetrium Bioscience (KOSDAQ 187660) today announced compelling new scientific evidence demonstrating, for the first time at the cellular level, the underlying mechanism behind the long-standing "Seed & Soil" theory originally proposed by Stephen Paget in 1889. The findings reveal how pathological tumor microenvironments ("soil") fundamentally limit the efficacy of targeted therapies—and how Penetrium's novel approach overcomes this barrier.</description>
</item>
<item>
<title>BlackBerry, JVCKENWOOD and SK Telecom Join Sisvel POS Patent Pool as Licensors</title>
<link>https://6ix.com/news/blackberry-jvckenwood-and-sk-telecom-join-sisvel-pos-patent-pool-as-licensors-3</link>
<guid isPermaLink="true">https://6ix.com/news/blackberry-jvckenwood-and-sk-telecom-join-sisvel-pos-patent-pool-as-licensors-3</guid>
<pubDate>Fri, 17 Apr 2026 07:04:00 GMT</pubDate>
<description>LUXEMBOURG, April 17, 2026--The new Sisvel Point of Sale (POS) patent pool, announced on 1 April, has added three new licensors in the last two weeks. BlackBerry, JVCKENWOOD and SK Telecom have joined founding licensors Huawei, LG Electronics and Nokia in making their patents available for license through the programme.</description>
</item>
<item>
<title>NETMARBLE TO HOST ONLINE SHOWCASE FOR GAME OF THRONES: KINGSROAD TODAY, STEAM PLAYTEST NOW LIVE</title>
<link>https://6ix.com/news/netmarble-to-host-online-showcase-for-game-of-thrones-kingsroad-today-steam-playtest-now-live</link>
<guid isPermaLink="true">https://6ix.com/news/netmarble-to-host-online-showcase-for-game-of-thrones-kingsroad-today-steam-playtest-now-live</guid>
<pubDate>Fri, 17 Apr 2026 05:30:00 GMT</pubDate>
<description>Netmarble, a leading developer and publisher of high-quality games, will host its online showcase for Game of Thrones: Kingsroad today at 11AM(UTC) via its official YouTube channel.</description>
</item>
<item>
<title>Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice</title>
<link>https://6ix.com/news/lunit-surpasses-330-sites-and-1m-annual-screenings-as-breast-imaging-ai-moves-into-clinical-practice</link>
<guid isPermaLink="true">https://6ix.com/news/lunit-surpasses-330-sites-and-1m-annual-screenings-as-breast-imaging-ai-moves-into-clinical-practice</guid>
<pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
<description>At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise deployment of its AI-powered breast cancer ecosystem, and FDA clearance of its next-generation 3D mammography AI.</description>
</item>
<item>
<title>LG ELECTRONICS SHOWCASES INNOVATION AND GROWTH STRATEGY FOR ASIA AT LG INNOFEST 2026 APAC</title>
<link>https://6ix.com/news/lg-electronics-showcases-innovation-and-growth-strategy-for-asia-at-lg-innofest-2026-apac</link>
<guid isPermaLink="true">https://6ix.com/news/lg-electronics-showcases-innovation-and-growth-strategy-for-asia-at-lg-innofest-2026-apac</guid>
<pubDate>Tue, 14 Apr 2026 07:42:00 GMT</pubDate>
<description>LG Electronics (LG) is showcasing its latest products and region‑specific solutions at LG InnoFest 2026 APAC, held in Busan, Korea, from April 7–10. The event marks the grand finale of LG's 2026 InnoFest series, bringing together more than 200 key partners and media representatives from approximately 20 countries across the Asia-Pacific region to strengthen collaboration and share business strategies.</description>
</item>
<item>
<title>Critical Loop Raises $26M Series A to Accelerate Grid Interconnection</title>
<link>https://6ix.com/news/critical-loop-raises-dollar26m-series-a-to-accelerate-grid-interconnection-1</link>
<guid isPermaLink="true">https://6ix.com/news/critical-loop-raises-dollar26m-series-a-to-accelerate-grid-interconnection-1</guid>
<pubDate>Mon, 13 Apr 2026 14:00:00 GMT</pubDate>
<description>LOS ANGELES, April 13, 2026--Critical Loop, an industrial power solutions company, today announced a $26 million Series A round led by Conifer Infrastructure Partners and Hanover, with participation from Better Ventures, Climate Capital, Adapt Nation Capital, and Cyrus Ventures. The raise brings total committed equity and debt funding to date for the company to $49 million and will accelerate the company's work with partners, including San Diego International Airport, supported by a supply agree</description>
</item>
<item>
<title>Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026</title>
<link>https://6ix.com/news/orion-publishes-interim-report-for-january-march-2026-and-holds-a-webcast-on-23-april-2026</link>
<guid isPermaLink="true">https://6ix.com/news/orion-publishes-interim-report-for-january-march-2026-and-holds-a-webcast-on-23-april-2026</guid>
<pubDate>Fri, 10 Apr 2026 06:00:00 GMT</pubDate>
<description>ORION CORPORATION PRESS RELEASE 10 APRIL 2026 at 9.00 EEST Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026 Orion will publish Interim Report for January–March 2026 on Thursday, 23 April 2026 at approximately 12.00 noon EEST. The release and related presentation material will be available on the company’s website at www.orionpharma.com/investors after publishing. Webcast and conference call A webcast and a conference call for analysts, investors and medi</description>
</item>
<item>
<title>HD Hyundai Heavy Industries Builds World's First Ammonia-Powered Vessel</title>
<link>https://6ix.com/news/hd-hyundai-heavy-industries-builds-worlds-first-ammonia-powered-vessel</link>
<guid isPermaLink="true">https://6ix.com/news/hd-hyundai-heavy-industries-builds-worlds-first-ammonia-powered-vessel</guid>
<pubDate>Thu, 09 Apr 2026 05:41:00 GMT</pubDate>
<description>HD Hyundai Heavy Industries (HHI) said it has built the world's first ammonia-powered vessel and held a naming ceremony on March 9 for two such ships at its Ulsan shipyard.</description>
</item>
<item>
<title>GAME ON: LG KICKS OFF PRE-ORDERS FOR ULTRAGEAR EVO GX9 AND GM9 GAMING MONITORS</title>
<link>https://6ix.com/news/game-on-lg-kicks-off-pre-orders-for-ultragear-evo-gx9-and-gm9-gaming-monitors</link>
<guid isPermaLink="true">https://6ix.com/news/game-on-lg-kicks-off-pre-orders-for-ultragear-evo-gx9-and-gm9-gaming-monitors</guid>
<pubDate>Tue, 07 Apr 2026 12:00:00 GMT</pubDate>
<description>LG Electronics, the #1 OLED Gaming Monitor Brand in the USA1, today announced pricing and availability for two new additions to its 2026 UltraGear evo gaming monitor lineup: the LG UltraGear evo GX9 (model: 39GX950B-B), the world's first 39-inch 5K2K curved OLED gaming monitor2, and the LG UltraGear evo GM9 (model: 27GM950B-B), a 27-inch 5K Hyper Mini LED gaming monitor. Both monitors bring next-generation display performance and AI-powered features to competitive and immersive gaming, giving pl</description>
</item>
<item>
<title>Mayor of Plano, U.S., Visits SK Signet Headquarters to Strengthen North American EV Charging Infrastructure Partnership</title>
<link>https://6ix.com/news/mayor-of-plano-us-visits-sk-signet-headquarters-to-strengthen-north-american-ev-charging-infrastructure-partnership</link>
<guid isPermaLink="true">https://6ix.com/news/mayor-of-plano-us-visits-sk-signet-headquarters-to-strengthen-north-american-ev-charging-infrastructure-partnership</guid>
<pubDate>Mon, 06 Apr 2026 12:30:00 GMT</pubDate>
<description>SK Signet (KONEX: 260870), a global manufacturer of high-power EV charging solutions based in South Korea, announced on April 2nd that the Mayor of Plano, Texas, and an official delegation visited its headquarters and the R&D center.</description>
</item>
<item>
<title>SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting</title>
<link>https://6ix.com/news/sk-life-science-inc-to-present-new-data-and-epilepsy-insights-at-the-2026-american-academy-of-neurology-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/news/sk-life-science-inc-to-present-new-data-and-epilepsy-insights-at-the-2026-american-academy-of-neurology-annual-meeting</guid>
<pubDate>Mon, 06 Apr 2026 12:04:00 GMT</pubDate>
<description>SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals Co., Ltd., today announced that it will present multiple posters at the American Academy of Neurology (AAN)Annual Meeting, taking place April 18–22, 2026, in Chicago, Illinois.</description>
</item>
<item>
<title>HAFNIA LIMITED: Hafnia Enters into Newbuild Agreement for Eight Medium-Range (MR) Product Tankers</title>
<link>https://6ix.com/news/hafnia-limited-hafnia-enters-into-newbuild-agreement-for-eight-medium-range-mr-product-tankers-2</link>
<guid isPermaLink="true">https://6ix.com/news/hafnia-limited-hafnia-enters-into-newbuild-agreement-for-eight-medium-range-mr-product-tankers-2</guid>
<pubDate>Fri, 03 Apr 2026 06:14:00 GMT</pubDate>
<description>SINGAPORE, April 03, 2026--Hafnia Limited ("Hafnia" or the "Company", OSE ticker code: "HAFNI", NYSE ticker code: "HAFN") announces that it has signed a contract for the construction of eight Medium-Range (MR) newbuild product tankers at Hyundai Heavy Industries.</description>
</item>
<item>
<title>LG Energy Solution Becomes First Battery Company to Join SDVerse, Global B2B Marketplace for Automotive Software</title>
<link>https://6ix.com/news/lg-energy-solution-becomes-first-battery-company-to-join-sdverse-global-b2b-marketplace-for-automotive-software</link>
<guid isPermaLink="true">https://6ix.com/news/lg-energy-solution-becomes-first-battery-company-to-join-sdverse-global-b2b-marketplace-for-automotive-software</guid>
<pubDate>Fri, 03 Apr 2026 00:36:00 GMT</pubDate>
<description>LG Energy Solution announced today that it has joined SDVerse, becoming the first battery company to participate. This move underscores the company's technological leadership as it expands beyond battery manufacturing into the software and services that power next-generation vehicles.</description>
</item>
<item>
<title>Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines</title>
<link>https://6ix.com/news/change-in-orion-group-executive-team-as-of-8-april-2026-berkeley-vincent-appointed-executive-vice-president-innovative-medicines-6</link>
<guid isPermaLink="true">https://6ix.com/news/change-in-orion-group-executive-team-as-of-8-april-2026-berkeley-vincent-appointed-executive-vice-president-innovative-medicines-6</guid>
<pubDate>Wed, 01 Apr 2026 13:00:00 GMT</pubDate>
<description>Berkeley Vincent Photo of Berkeley Vincent ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS1 APRIL 2026 at 16.00 EEST Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines Orion Corporation (“Orion”) has appointed Berkeley Vincent as Executive Vice President, Innovative Medicines and a member of the Orion Executive Team as of 8 April 2026. The appointment is part of a leadership structure ch</description>
</item>
<item>
<title>Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool</title>
<link>https://6ix.com/news/huawei-lg-electronics-and-nokia-named-as-founder-licensors-of-new-sisvel-pos-pool-1</link>
<guid isPermaLink="true">https://6ix.com/news/huawei-lg-electronics-and-nokia-named-as-founder-licensors-of-new-sisvel-pos-pool-1</guid>
<pubDate>Wed, 01 Apr 2026 10:17:00 GMT</pubDate>
<description>LUXEMBOURG, April 01, 2026--Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today.</description>
</item>
<item>
<title>Hugel to enter ECM-based injectable market with aesthetic portfolio expansion</title>
<link>https://6ix.com/news/hugel-to-enter-ecm-based-injectable-market-with-aesthetic-portfolio-expansion</link>
<guid isPermaLink="true">https://6ix.com/news/hugel-to-enter-ecm-based-injectable-market-with-aesthetic-portfolio-expansion</guid>
<pubDate>Wed, 01 Apr 2026 02:30:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an extracellular matrix (ECM)-based injectable treatment to its portfolio.</description>
</item>
<item>
<title>Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights</title>
<link>https://6ix.com/news/aptose-biosciences-announces-results-of-special-shareholders-meeting-announces-receipt-of-final-court-approval-of-plan-of-arrangement-reports-year-end-2025-results-and-corporate-highlights-2</link>
<guid isPermaLink="true">https://6ix.com/news/aptose-biosciences-announces-results-of-special-shareholders-meeting-announces-receipt-of-final-court-approval-of-plan-of-arrangement-reports-year-end-2025-results-and-corporate-highlights-2</guid>
<pubDate>Tue, 31 Mar 2026 21:22:00 GMT</pubDate>
<description>Shareholders approve acquisition of Aptose by Hanmi Pharmaceutical in “Go Private” transaction TUS+VEN+AZA triplet frontline therapy continues to demonstrate favorable safety and high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutations SAN DIEGO and TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-base</description>
</item>
<item>
<title>Excelerate Energy Names New FSRU Excelerate Acadia at HD Hyundai Heavy Industries</title>
<link>https://6ix.com/news/excelerate-energy-names-new-fsru-excelerate-acadia-at-hd-hyundai-heavy-industries-2</link>
<guid isPermaLink="true">https://6ix.com/news/excelerate-energy-names-new-fsru-excelerate-acadia-at-hd-hyundai-heavy-industries-2</guid>
<pubDate>Tue, 31 Mar 2026 20:15:00 GMT</pubDate>
<description>THE WOODLANDS, Texas, March 31, 2026--Excelerate Energy, Inc. (NYSE:EE) today announced the official naming of its newest floating storage and regasification unit, Excelerate Acadia, during a naming ceremony at the Hyundai Heavy Industries shipyard in Ulsan, South Korea.</description>
</item>
<item>
<title>Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland</title>
<link>https://6ix.com/news/samsung-biologics-completes-acquisition-of-gsks-manufacturing-facility-in-rockville-maryland</link>
<guid isPermaLink="true">https://6ix.com/news/samsung-biologics-completes-acquisition-of-gsks-manufacturing-facility-in-rockville-maryland</guid>
<pubDate>Tue, 31 Mar 2026 14:00:00 GMT</pubDate>
<description>Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States.</description>
</item>
<item>
<title>Lotte Rental Speeds Growth and Innovation with Multiyear Partnership with Rimini Street</title>
<link>https://6ix.com/news/lotte-rental-speeds-growth-and-innovation-with-multiyear-partnership-with-rimini-street-1</link>
<guid isPermaLink="true">https://6ix.com/news/lotte-rental-speeds-growth-and-innovation-with-multiyear-partnership-with-rimini-street-1</guid>
<pubDate>Tue, 31 Mar 2026 13:00:00 GMT</pubDate>
<description>LAS VEGAS, March 31, 2026--Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Lotte Rental, South Korea’s leading car rental company, has selected Rimini Street to provide support for its Oracle and SAP systems.</description>
</item>
<item>
<title>Amorepacific Corp.: Amorepacific, Viol Medical Sign MOU on Beauty and Medical Devices</title>
<link>https://6ix.com/company/amorepacific-corp-new/news/amorepacific-viol-medical-sign-mou-on-beauty-and-medical-devices</link>
<guid isPermaLink="true">https://6ix.com/company/amorepacific-corp-new/news/amorepacific-viol-medical-sign-mou-on-beauty-and-medical-devices</guid>
<pubDate>Tue, 31 Mar 2026 05:00:00 GMT</pubDate>
<description>Amorepacific announced on March 27 that it has signed a memorandum of understanding (MOU) with Viol Medical, an energy‑based medical device company, to collaborate in the beauty and medical device sectors. The collaboration aligns with Amorepacific's long‑term strategy to provide holistic beauty solutions that connect skincare with beauty devices.</description>
</item>
<item>
<title>/C O R R E C T I O N -- LG Electronics USA/</title>
<link>https://6ix.com/news/c-o-r-r-e-c-t-i-o-n-lg-electronics-usa</link>
<guid isPermaLink="true">https://6ix.com/news/c-o-r-r-e-c-t-i-o-n-lg-electronics-usa</guid>
<pubDate>Mon, 30 Mar 2026 13:49:00 GMT</pubDate>
<description>LG Electronics USA (LG) today announced a partnership with production company Simple Alien to launch ALL CHEWED UP on LG Channels, LG's free ad-supported streaming TV (FAST) platform powered by the webOS smart TV platform. The new creator-owned culinary and lifestyle channel launches March 30, 2026, with more than 70 episodes of its flagship series, CHEWED UP — hosted and co-owned by culinary personalities Carla Hall, Clinton Kelly, Michael Symon and Simple Alien — available to viewers on day on</description>
</item>
<item>
<title>Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs</title>
<link>https://6ix.com/news/lunit-cellcarta-announce-strategic-collaboration-to-accelerate-ai-enabled-digital-pathology-for-companion-diagnostic-programs</link>
<guid isPermaLink="true">https://6ix.com/news/lunit-cellcarta-announce-strategic-collaboration-to-accelerate-ai-enabled-digital-pathology-for-companion-diagnostic-programs</guid>
<pubDate>Mon, 30 Mar 2026 07:15:00 GMT</pubDate>
<description>Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a leading global contract research organization (CRO) laboratory to the biopharmaceutical industry, today announced a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows across translational research, clinical trials and companion diagnostic (CDx) programs.</description>
</item>
<item>
<title>Rönesans Holding Announces New Global Partnership</title>
<link>https://6ix.com/news/ronesans-holding-announces-new-global-partnership</link>
<guid isPermaLink="true">https://6ix.com/news/ronesans-holding-announces-new-global-partnership</guid>
<pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
<description>Rönesans Holding has announced a strategic partnership with SJ Group, as part of the development of the Eastern Mediterranean Petrochemical Industrial Zone and Port (DAPEK) project in Ceyhan, Adana.</description>
</item>
<item>
<title>Genians Recognizes 2025 Partner of the Year Winners as Global Footprint Expands Across Key Markets</title>
<link>https://6ix.com/news/genians-recognizes-2025-partner-of-the-year-winners-as-global-footprint-expands-across-key-markets</link>
<guid isPermaLink="true">https://6ix.com/news/genians-recognizes-2025-partner-of-the-year-winners-as-global-footprint-expands-across-key-markets</guid>
<pubDate>Tue, 24 Mar 2026 14:47:00 GMT</pubDate>
<description>SAN JOSE, Calif., March 24, 2026--Genians, a network security company serving 5,000+ organizations globally, has announced its annual Partner of the Year recipients. Winners were selected based on new customer acquisition, vertical market penetration, and execution in compliance-driven environments.</description>
</item>
<item>
<title>Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026</title>
<link>https://6ix.com/news/decisions-taken-by-orion-corporations-annual-general-meeting-and-board-of-directors-organising-meeting-on-24-march-2026</link>
<guid isPermaLink="true">https://6ix.com/news/decisions-taken-by-orion-corporations-annual-general-meeting-and-board-of-directors-organising-meeting-on-24-march-2026</guid>
<pubDate>Tue, 24 Mar 2026 14:30:00 GMT</pubDate>
<description>ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING24 MARCH 2026 at 16.30 EET Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026 At the Annual General Meeting of Orion Corporation held today, the following decisions were made: A dividend of EUR 1.80 per share was confirmed to be paid. The dividend is paid in two instalments.The proposals concerning the election and remuneration of the Board of Directors, t</description>
</item>
<item>
<title>SK Signet Launches 400kW All-In-One Ultra-Fast Charger to Accelerate Global Market Expansion</title>
<link>https://6ix.com/news/sk-signet-launches-400kw-all-in-one-ultra-fast-charger-to-accelerate-global-market-expansion</link>
<guid isPermaLink="true">https://6ix.com/news/sk-signet-launches-400kw-all-in-one-ultra-fast-charger-to-accelerate-global-market-expansion</guid>
<pubDate>Mon, 23 Mar 2026 12:30:00 GMT</pubDate>
<description>SEOUL, South Korea, March 23, 2026--SK Signet, an EV charging solutions provider, has launched its new 400kW All-in-One ultra-fast EV charger, expanding its supply to global markets.</description>
</item>
<item>
<title>NETMARBLE STEAM PLAYTEST SIGN-UPS UNDERWAY FOR GAME OF THRONES: KINGSROAD</title>
<link>https://6ix.com/news/netmarble-steam-playtest-sign-ups-underway-for-game-of-thrones-kingsroad</link>
<guid isPermaLink="true">https://6ix.com/news/netmarble-steam-playtest-sign-ups-underway-for-game-of-thrones-kingsroad</guid>
<pubDate>Mon, 23 Mar 2026 03:00:00 GMT</pubDate>
<description>Netmarble, a leading developer and publisher of high-quality games, is currently accepting sign-ups for the upcoming Steam Playtest for Game of Thrones: Kingsroad ahead of its launch in Asia.</description>
</item>
<item>
<title>Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical</title>
<link>https://6ix.com/news/leading-independent-proxy-advisory-firm-iss-recommends-aptose-biosciences-shareholders-vote-for-proposed-plan-of-arrangement-with-hanmi-pharmaceutical</link>
<guid isPermaLink="true">https://6ix.com/news/leading-independent-proxy-advisory-firm-iss-recommends-aptose-biosciences-shareholders-vote-for-proposed-plan-of-arrangement-with-hanmi-pharmaceutical</guid>
<pubDate>Thu, 19 Mar 2026 11:30:00 GMT</pubDate>
<description>SAN DIEGO and TORONTO, March 19, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) today announced that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that Aptose shareholders (“Shareholders”) vote ”FOR” a special resolution (the “Arrangement Resolution”) to approve the previously announced arrangement (the “Arrangement”) pursuant to which Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North</description>
</item>
<item>
<title>SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support</title>
<link>https://6ix.com/news/sk-bioscience-secures-funding-to-advance-rsv-preventive-antibody-development-with-right-foundation-support</link>
<guid isPermaLink="true">https://6ix.com/news/sk-bioscience-secures-funding-to-advance-rsv-preventive-antibody-development-with-right-foundation-support</guid>
<pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
<description>SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health Technology Foundation (RIGHT Foundation) to receive financial support for early clinical development of its RSV (respiratory syncytial virus) preventive monoclonal antibody candidate, RSM01.</description>
</item>
<item>
<title>Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership</title>
<link>https://6ix.com/news/peace-through-well-being-orion-and-cmi-martti-ahtisaari-peace-foundation-announce-partnership</link>
<guid isPermaLink="true">https://6ix.com/news/peace-through-well-being-orion-and-cmi-martti-ahtisaari-peace-foundation-announce-partnership</guid>
<pubDate>Wed, 18 Mar 2026 08:00:00 GMT</pubDate>
<description>ORION CORPORATION PRESS RELEASE 18 March 2026 at 10:00 EET Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership Orion Corporation (“Orion Pharma”) and CMI - Martti Ahtisaari Peace Foundation (“CMI”) have entered a strategic content partnership for 2026. The partnership channels insights from CMI’s peace mediation experts, turning decades of peace process experience into clear and accessible content for a broad audience. “At Orion Pharma, we believe tha</description>
</item>
<item>
<title>MAA Announces Quarterly Common Dividend</title>
<link>https://6ix.com/news/maa-announces-quarterly-common-dividend-3</link>
<guid isPermaLink="true">https://6ix.com/news/maa-announces-quarterly-common-dividend-3</guid>
<pubDate>Tue, 17 Mar 2026 20:15:00 GMT</pubDate>
<description>Mid-America Apartment Communities, Inc., or MAA (NYSE: MAA), today announced that its board of directors approved a quarterly dividend payment of $1.53 per share of common stock to be paid on April 30, 2026, to shareholders of record on April 15, 2026.</description>
</item>
</channel>
</rss>